Hepatitis B virus X protein accelerates the development of hepatoma
- PMID: 25364579
- PMCID: PMC4197427
- DOI: 10.7497/j.issn.2095-3941.2014.03.004
Hepatitis B virus X protein accelerates the development of hepatoma
Abstract
The chronic infection of hepatitis B virus (HBV) is closely related to the occurrence and development of hepatocellular carcinoma (HCC). Accumulated evidence has shown that HBV X protein (HBx protein) is a multifunctional regulator with a crucial role in hepatocarcinogenesis. However, information on the mechanism by which HBV induces HCC is lacking. This review focuses on the pathological functions of HBx in HBV-induced hepatocarcinogenesis. As a transactivator, HBx can modulate nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and transcription factor AP-2. Moreover, HBx can affect regulatory non-coding RNAs (ncRNAs) including microRNAs and long ncRNAs (lncRNAs), such as miRNA-205 and highly upregulated in liver cancer (HULC), respectively. HBx is also involved in epigenetic modification, including methylation and acetylation. HBx interacts with various signal-transduction pathways, such as protein kinase B/Akt, Wnt/β-catenin, signal transducer and activator of transcription, and NF-κB pathways. Moreover, HBx affects cellular fate by shifting the balance toward cell survival. HBx may lead to the loss of apoptotic functions or directly contributes to oncogenesis by achieving transforming functions, which induce hepatocarcinogenesis. Additionally, HBx can modulate apoptosis and immune response by direct or indirect interaction with host factors. We conclude that HBx hastens the development of hepatoma.
Keywords: HBV X protein (HBx protein); Hepatocellular carcinoma (HCC); hepatitis B virus (HBV); hepatocarcinogenesis.
Conflict of interest statement
No potential conflicts of interest are disclosed.
Similar articles
-
Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis.World J Gastroenterol. 2015 Oct 14;21(38):10732-8. doi: 10.3748/wjg.v21.i38.10732. World J Gastroenterol. 2015. PMID: 26478665 Free PMC article. Review.
-
Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.J Exp Clin Cancer Res. 2016 Nov 7;35(1):172. doi: 10.1186/s13046-016-0448-2. J Exp Clin Cancer Res. 2016. PMID: 27821177 Free PMC article.
-
Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.Int J Cancer. 2014 Aug 1;135(3):635-46. doi: 10.1002/ijc.28697. Epub 2014 Jan 13. Int J Cancer. 2014. PMID: 24374650
-
Hepatitis B virus X protein (HBx) enhances centrosomal P4.1-associated protein (CPAP) expression to promote hepatocarcinogenesis.J Biomed Sci. 2019 Jun 6;26(1):44. doi: 10.1186/s12929-019-0534-9. J Biomed Sci. 2019. PMID: 31170980 Free PMC article.
-
The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates.Explor Target Antitumor Ther. 2024;5(1):120-134. doi: 10.37349/etat.2024.00209. Epub 2024 Feb 20. Explor Target Antitumor Ther. 2024. PMID: 38464387 Free PMC article. Review.
Cited by
-
Immunohistochemical Expression of Upregulated Gene 4 Protein Expression (URG4/URGCP) and Its Association with 5-Year Survival in Patients with Colon Adenocarcinoma.J Clin Med. 2023 Aug 23;12(17):5477. doi: 10.3390/jcm12175477. J Clin Med. 2023. PMID: 37685545 Free PMC article.
-
Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.World J Gastroenterol. 2016 Jan 7;22(1):176-87. doi: 10.3748/wjg.v22.i1.176. World J Gastroenterol. 2016. PMID: 26755869 Free PMC article. Review.
-
New horizon for radical cure of chronic hepatitis B virus infection.World J Hepatol. 2016 Jul 28;8(21):863-73. doi: 10.4254/wjh.v8.i21.863. World J Hepatol. 2016. PMID: 27478536 Free PMC article.
-
miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.World J Gastroenterol. 2016 Jun 14;22(22):5183-92. doi: 10.3748/wjg.v22.i22.5183. World J Gastroenterol. 2016. PMID: 27298561 Free PMC article.
-
Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.J Transl Med. 2018 Jun 28;16(1):177. doi: 10.1186/s12967-018-1546-z. J Transl Med. 2018. PMID: 29954402 Free PMC article.
References
-
- Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 2010;58:273-277 - PubMed
-
- Zhang X, Zhang H, Ye L.Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 2006;147:58-66 - PubMed
-
- Nakatake H, Chisaka O, Yamamoto S, Matsubara K, Koshy R.Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. Virology 1993;195:305-314 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials